InnoCan Pharma Corporation (QB) (INNPF)
USOTC
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 8k | 196k | 2.56M | 13.66M |
Operating Income | -1.17M | -2.77M | -4.5M | -7.27M | -5.81M | -3.51M |
Pre Tax Income | -1.19M | -3.34M | -9.95M | -10.09M | -3.89M | -4.03M |
Net Income | -1.19M | -3.34M | -9.95M | -10.05M | -3.76M | -4.7M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -8.962 | -0.023 | -0.053 | -0.04 | -0.015 | -0.018 |
EBIT | -1.17M | -2.77M | -4.5M | -7.27M | -5.81M | -3.48M |
EBITDA | -1.17M | -2.75M | -4.46M | -7.22M | -5.78M | -3.51M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.